Related Experiment Video
Updated: Jun 21, 2026
10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis.
Luisa P Cacheaux1, Sebastian Ivens, Yaron David
1Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California 94720-3140, USA.
Summary
Albumin triggers epilepsy after brain injury by activating the TGF-beta pathway. Blocking this pathway prevents epilepsy, identifying it as a new therapeutic target for neurological disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Epilepsy is a common neurological disorder often developing after brain injury.
- Blood-brain barrier (BBB) compromise is linked to post-injury epilepsy.
- Albumin's role in epilepsy generation after BBB compromise was previously established.
Purpose of the Study:
- To identify the molecular mechanism underlying albumin-induced epilepsy.
- To investigate the involvement of the TGF-beta pathway in epilepsy development.
- To explore TGF-beta pathway blockers as a potential therapeutic strategy.
Main Methods:
- Direct activation of the TGF-beta pathway using TGF-beta1.
- Coimmunoprecipitation to assess albumin binding to TGF-beta receptor II.
- Smad2 phosphorylation assays to confirm pathway activation.
- Transcriptome profiling to analyze gene expression changes.
- Assessment of TGF-beta pathway blockers' efficacy.
Main Results:
- Direct TGF-beta pathway activation mimicked albumin-induced epileptiform activity.
- Albumin directly binds to TGF-beta receptor II, activating the downstream Smad2 pathway.
- Transcriptome analysis revealed similar gene expression patterns for BBB breakdown, albumin, and TGF-beta1 exposure.
- Key affected genes were associated with the TGF-beta pathway, astrocytic activation, inflammation, and altered inhibitory transmission.
- TGF-beta pathway blockers significantly reduced albumin-induced transcriptional changes and prevented epileptiform activity.
Conclusions:
- The TGF-beta pathway is a novel signaling cascade involved in epilepsy generation after brain injury.
- Albumin initiates epileptogenesis by activating the TGF-beta pathway.
- Targeting the TGF-beta pathway offers a promising therapeutic strategy for preventing injury-induced epilepsy.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...